131 related articles for article (PubMed ID: 12767114)
1. Oligopeptide inhibition of class I ribonucleotide reductases.
Cooperman BS
Biopolymers; 2003; 71(2):117-31. PubMed ID: 12767114
[TBL] [Abstract][Full Text] [Related]
2. A solid-phase assay for the binding of peptidic subunit association inhibitors to the herpes simplex virus ribonucleotide reductase large subunit.
Krogsrud RL; Welchner E; Scouten E; Liuzzi M
Anal Biochem; 1993 Sep; 213(2):386-94. PubMed ID: 8238915
[TBL] [Abstract][Full Text] [Related]
3. Affinity of synthetic peptides for the HSV-2 ribonucleotide reductase R1 subunit measured with an iodinated photoaffinity peptide.
Lamarche N; Gaudreau P; Massie B; Langelier Y
Anal Biochem; 1994 Aug; 220(2):315-20. PubMed ID: 7978273
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of chlamydial class Ic ribonucleotide reductase by C-terminal peptides from protein R2.
Ohrström M; Popović-Bijelić A; Luo J; Stenmark P; Högbom M; Gräslund A
J Pept Sci; 2011 Nov; 17(11):756-62. PubMed ID: 21976435
[TBL] [Abstract][Full Text] [Related]
5. Peptide inhibitors of mammalian ribonucleotide reductase.
Cooperman BS; Gao Y; Tan C; Kashlan OB; Kaur J
Adv Enzyme Regul; 2005; 45():112-25. PubMed ID: 16054677
[TBL] [Abstract][Full Text] [Related]
6. More potent linear peptide inhibitors of mammalian ribonucleotide reductase.
Tan C; Gao Y; Kaur J; Cooperman BS
Bioorg Med Chem Lett; 2004 Nov; 14(21):5301-4. PubMed ID: 15454215
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of action of peptide inhibitors of mammalian ribonucleotide reductase targeting quaternary structure.
Gao Y; Kashlan OB; Kaur J; Tan C; Cooperman BS
Biopolymers; 2005; 80(1):9-17. PubMed ID: 15586357
[TBL] [Abstract][Full Text] [Related]
8. Characterization of heterosubunit complexes formed by the R1 and R2 subunits of herpes simplex virus 1 and equine herpes virus 4 ribonucleotide reductase.
Sun Y; Conner J
Biochem J; 2000 Apr; 347 Pt 1(Pt 1):97-104. PubMed ID: 10727407
[TBL] [Abstract][Full Text] [Related]
9. Peptidomimetic inhibitors of herpes simplex virus ribonucleotide reductase with improved in vivo antiviral activity.
Moss N; Beaulieu P; Duceppe JS; Ferland JM; Garneau M; Gauthier J; Ghiro E; Goulet S; Guse I; Jaramillo J; Llinas-Brunet M; Malenfant E; Plante R; Poirier M; Soucy F; Wernic D; Yoakim C; Déziel R
J Med Chem; 1996 Oct; 39(21):4173-80. PubMed ID: 8863795
[TBL] [Abstract][Full Text] [Related]
10. Resistance of herpes simplex virus type 1 to peptidomimetic ribonucleotide reductase inhibitors: selection and characterization of mutant isolates.
Bonneau AM; Kibler P; White P; Bousquet C; Dansereau N; Cordingley MG
J Virol; 1996 Feb; 70(2):787-93. PubMed ID: 8551616
[TBL] [Abstract][Full Text] [Related]
11. R2 C-terminal peptide inhibition of mammalian and yeast ribonucleotide reductase.
Fisher A; Yang FD; Rubin H; Cooperman BS
J Med Chem; 1993 Nov; 36(24):3859-62. PubMed ID: 8254617
[TBL] [Abstract][Full Text] [Related]
12. Specific inhibition of herpesvirus ribonucleotide reductase by synthetic peptides.
Dutia BM; Frame MC; Subak-Sharpe JH; Clark WN; Marsden HS
Nature; 1986 May 22-28; 321(6068):439-41. PubMed ID: 3012359
[TBL] [Abstract][Full Text] [Related]
13. Ureido-based peptidomimetic inhibitor of herpes simplex virus ribonucleotide reductase: an investigation of inhibitor bioactive conformation.
Moss N; Beaulieu P; Duceppe JS; Ferland JM; Gauthier J; Ghiro E; Goulet S; Guse I; Llinàs-Brunet M; Plante R; Plamondon L; Wernic D; Déziel R
J Med Chem; 1996 May; 39(11):2178-87. PubMed ID: 8667361
[TBL] [Abstract][Full Text] [Related]
14. Specific inhibition of herpesvirus ribonucleotide reductase by a nonapeptide derived from the carboxy terminus of subunit 2.
Cohen EA; Gaudreau P; Brazeau P; Langelier Y
Nature; 1986 May 22-28; 321(6068):441-3. PubMed ID: 3012360
[TBL] [Abstract][Full Text] [Related]
15. The first holocomplex structure of ribonucleotide reductase gives new insight into its mechanism of action.
Uppsten M; Färnegårdh M; Domkin V; Uhlin U
J Mol Biol; 2006 Jun; 359(2):365-77. PubMed ID: 16631785
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of equine herpesvirus type 1 subtype 1-induced ribonucleotide reductase by the nonapeptide YAGAVVNDL.
Telford E; Lankinen H; Marsden H
J Gen Virol; 1990 Jun; 71 ( Pt 6)():1373-8. PubMed ID: 2161904
[TBL] [Abstract][Full Text] [Related]
17. Understanding the molecular mechanism of viral resistance to peptidomimetic inhibitors of ribonucleotide reductase.
White PW
Biochim Biophys Acta; 1998 Jan; 1382(1):102-10. PubMed ID: 9507079
[TBL] [Abstract][Full Text] [Related]
18. The carboxyl terminus heptapeptide of the R2 subunit of mammalian ribonucleotide reductase inhibits enzyme activity and can be used to purify the R1 subunit.
Yang FD; Spanevello RA; Celiker I; Hirschmann R; Rubin H; Cooperman BS
FEBS Lett; 1990 Oct; 272(1-2):61-4. PubMed ID: 2226836
[TBL] [Abstract][Full Text] [Related]
19. The structural basis for peptidomimetic inhibition of eukaryotic ribonucleotide reductase: a conformationally flexible pharmacophore.
Xu H; Fairman JW; Wijerathna SR; Kreischer NR; LaMacchia J; Helmbrecht E; Cooperman BS; Dealwis C
J Med Chem; 2008 Aug; 51(15):4653-9. PubMed ID: 18610997
[TBL] [Abstract][Full Text] [Related]
20. Oligopeptides inhibit the ribonucleotide reductase of herpes simplex virus by causing subunit separation.
McClements W; Yamanaka G; Garsky V; Perry H; Bacchetti S; Colonno R; Stein RB
Virology; 1988 Jan; 162(1):270-3. PubMed ID: 2827385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
